Belpointe Asset Management LLC Ligand Pharmaceuticals Inc Transaction History

Belpointe Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$65.67 - $77.08 $394 - $462	6 Added 6.0%	106 $7,000
Q4 2022 Feb 08, 2023	BUY	$61.72 - $96.74 $6,172 - $9,674	100 New	100 $6,000
Q1 2020 Jul 20, 2020	SELL	$63.37 - $107.88 $83,965 - $142,941	-1,325 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$96.94 - $113.59 $9,694 - $11,359	-100 Reduced 7.02%	1,325 $138,000
Q3 2019 Jan 16, 2020	BUY	$86.25 - $120.16 $122,906 - $171,228	1,425 New	1,425 $142,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.